In the last 12 months, insiders at FibroBiologics, Inc. ($FBLG) filed 30 transactions with the SEC: 10 open-market purchases totaling $172,629 and 0 sales totaling $0. Net insider sentiment: net buying.
FibroBiologics, Inc. operates in the Pharmaceutical preparations industry (Life sciences sector).
Most Active Insiders
- GARCIA RUBEN A (General Counsel) — 5 transactions totaling $60,656
- Khoja Hamid (Chief Scientific Officer) — 3 transactions totaling $47,200
- Davis Jason (Chief Financial Officer) — 2 transactions totaling $28,973
- O'HEERON PETE (CHIEF EXECUTIVE OFFICER) — 4 transactions totaling $19,531
- O'HEERON PETE (Chief Executive Officer) — 4 transactions totaling $16,269
View all SEC Filings for FibroBiologics, Inc. (FBLG).
Set Up your own filters →Recent Insider Transactions
| Transaction Date | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|
| March 4, 2026 | Khoja Hamid | Chief Scientific Officer | P | Common Stock | 30000 | $0.38 | 61,250.0000 | 51,456,077 | 96.00% | 0.06% |
| March 2, 2026 | O'HEERON PETE | CHIEF EXECUTIVE OFFICER | P | Common Stock | 17428 | $0.35 | 5,924,075.0000 | 51,456,077 | 0.30% | 0.03% |
| March 3, 2026 | O'HEERON PETE | CHIEF EXECUTIVE OFFICER | P | Common Stock | 18200 | $0.41 | 5,942,275.0000 | 51,456,077 | 0.31% | 0.04% |
| March 4, 2026 | O'HEERON PETE | CHIEF EXECUTIVE OFFICER | P | Common Stock | 15872 | $0.38 | 5,958,147.0000 | 51,456,077 | 0.27% | 0.03% |
| March 2, 2026 | Davis Jason | Chief Financial Officer | P | Common Stock | 70000 | $0.41 | 70,000.0000 | 51,456,077 | 9999.99% | 0.14% |
| Feb. 27, 2026 | GARCIA RUBEN A | General Counsel | P | Common Stock | 40000 | $0.33 | 180,000.0000 | 51,456,077 | 28.57% | 0.08% |
| Dec. 11, 2025 | GARCIA RUBEN A | General Counsel | P | Common Stock | 140000 | $0.34 | 140,000.0000 | 51,456,077 | 9999.99% | 0.27% |
| June 12, 2025 | Niklas Victoria Ninon Olivia | Director | A | Stock Option (Right to Buy) | 22000 | $0.00 | 22,000.0000 | 37,735,300 | 9999.99% | 0.06% |
| June 12, 2025 | Link Matthew | Director | A | Stock Option (Right to Buy) | 22000 | $0.00 | 22,000.0000 | 37,735,300 | 9999.99% | 0.06% |
| June 12, 2025 | Hoffman Robert E. | Director | A | Stock Option (Right to Buy) | 22000 | $0.00 | 22,000.0000 | 37,735,300 | 9999.99% | 0.06% |
| June 12, 2025 | Coen Stacy Ann | Director | A | Stock Option (Right to Buy) | 22000 | $0.00 | 22,000.0000 | 37,735,300 | 9999.99% | 0.06% |
| June 12, 2025 | Cilento Richard C. Jr. | Director | A | Stock Option (Right to Buy) | 22000 | $0.00 | 22,000.0000 | 37,735,300 | 9999.99% | 0.06% |
| June 9, 2025 | Davis Jason | Chief Financial Officer | A | Stock Option (Right to Buy) | 450000 | $0.00 | 450,000.0000 | 37,735,300 | 9999.99% | 1.19% |
| May 27, 2025 | Khoja Hamid | Chief Scientific Officer | P | Common Stock | 20000 | $0.84 | 31,250.0000 | 37,735,300 | 177.78% | 0.05% |
| March 26, 2025 | Khoja Hamid | CHIEF SCIENTIFIC OFFICER | A | Stock Option (Right to Buy) | 189000 | $0.00 | 189,000.0000 | 0 | 9999.99% | 0.00% |
| March 26, 2025 | O'HEERON PETE | CHIEF EXECUTIVE OFFICER | A | Stock Option (Right to Buy) | 453000 | $0.00 | 453,000.0000 | 0 | 9999.99% | 0.00% |
| March 26, 2025 | GARCIA RUBEN A | General Counsel | A | Stock Option (Right to Buy) | 189000 | $0.00 | 189,000.0000 | 0 | 9999.99% | 0.00% |
| Dec. 27, 2024 | GARCIA RUBEN A | General Counsel | A | Stock Option (Right to Buy) | 176200 | $0.00 | 176,200.0000 | 0 | 9999.99% | 0.00% |
| Dec. 27, 2024 | Khoja Hamid | CHIEF SCIENTIFIC OFFICER | A | Stock Option (Right to Buy) | 176200 | $0.00 | 176,200.0000 | 0 | 9999.99% | 0.00% |
| Dec. 27, 2024 | O'HEERON PETE | Chief Executive Officer | A | Stock Option (Right to Buy) | 406339 | $0.00 | 406,339.0000 | 0 | 9999.99% | 0.00% |
| Dec. 9, 2024 | O'HEERON PETE | Chief Executive Officer | G | Common Stock | 100000 | $0.00 | 5,906,647.0000 | 0 | 1.66% | 0.00% |
| Dec. 3, 2024 | O'HEERON PETE | Chief Executive Officer | G | Common Stock | 50000 | $0.00 | 6,006,647.0000 | 0 | 0.83% | 0.00% |
| Aug. 27, 2024 | Cilento Richard C. Jr. | Director | A | Stock Option (Right to Buy) | 5000 | $0.00 | 5,000.0000 | 0 | 9999.99% | 0.00% |
| Aug. 27, 2024 | Link Matthew | Director | A | Stock Option (Right to Buy) | 5000 | $0.00 | 5,000.0000 | 0 | 9999.99% | 0.00% |
| Aug. 27, 2024 | Niklas Victoria Ninon Olivia | Director | A | Stock Option (Right to Buy) | 5000 | $0.00 | 5,000.0000 | 0 | 9999.99% | 0.00% |
| Aug. 27, 2024 | Coen Stacy Ann | Director | A | Stock Option (Right to Buy) | 5000 | $0.00 | 5,000.0000 | 0 | 9999.99% | 0.00% |
| Aug. 27, 2024 | Hoffman Robert E. | Director | A | Stock Option (Right to Buy) | 5000 | $0.00 | 5,000.0000 | 0 | 9999.99% | 0.00% |
| Aug. 12, 2024 | Khoja Hamid | Chief Scientific Officer | P | Common Stock | 10000 | $1.90 | 11,250.0000 | 0 | 800.00% | 0.00% |
| Aug. 12, 2024 | O'HEERON PETE | Chief Executive Officer | P | Common Stock | 8500 | $1.91 | 6,056,647.0000 | 0 | 0.14% | 0.00% |
| March 1, 2024 | GARCIA RUBEN A | General Counsel | A | Stock Option (Right to Buy) | 180000 | $0.00 | 180,000.0000 | 0 | 9999.99% | 0.00% |